Skip to content

Eli Lilly Benelux

Active
Public limited companyfounded 1969active for 57 yearsMarkiesstraat 1, 1000 Brussel, BelgiumKBO/BCE: BE 0406.754.454
Summary

Eli Lilly Benelux has been active since 1969 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €20.4m and a net result of €11.5m. Equity remains stable across the filed financial years (±0.1% per year). Its solvency ranks better than 28% of 6,081 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€294.3mturnover 2025
Staff
96.6 FTE
Equity
€20.4m
Profit
€11.5m
Financial health
89 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Parent
ELI LILLY NETHERLAND BV · 99.99%
Holdings
1
Auditor: EY Réviseurs d'Entreprises SRLAccounts 9 days early2 of 36 deeds read
Why 89raises riskLiquidity: current ratio 1.34lowers riskSize: turnover €294.3m, 96.6 FTE, total assets €79.7mFounded in 1969Legal form: public limited companyShow the evidence

Checked score

Score 2025
89 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 50% of its sector peers (NACE 46, medium-sized)
Financial strength · tick = 2024
Average
Solvency 51-13
equity 25.6% of total assets
Liquidity 20-16
short-term debt 74.4%
Profitability 72+2
return on assets 14.4%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (746 companies, NACE 46, medium-sized)
Last 24 months 11-2024: 0.6% 12-2024: 0.7%▲ +0.1 percentage points vs 11-2024 01-2025: 1.3%▲ +0.6 percentage points vs 12-2024highest value 02-2025: 1.3%● unchanged vs 01-2025highest value 03-2025: 1.3%● unchanged vs 02-2025highest value 04-2025: 1.2%▼ -0.1 percentage points vs 03-2025 05-2025: 1.2%● unchanged vs 04-2025 06-2025: 1.2%● unchanged vs 05-2025 07-2025: 1.2%● unchanged vs 06-2025 08-2025: 0.2%▼ -1.0 percentage point vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026lowest value 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €1,800,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.34, compared with 1.63 in 2024; short-term debt: 74.4% of total assets), and 74.4% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, medium-sized): better than 32% on solvency, 20% on liquidity, 77% on profitability and 72% on growth.

The bankruptcy probability was computed on 09-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk○neutral
raises risk · Liquidity: current ratio 1.34
NBB · annual accounts
lowers risk · Size: turnover €294.3m, 96.6 FTE, total assets €79.7m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
lowers risk · Founded in 1969
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
lowers risk · Legal form: public limited company
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
9 days early
2024
2 days early
2023
12 days early
2022
4 days early
2021
5 days early
2020
11 days early
2019
25 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 3 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
10-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Reappointments: Sandrine Ferrière (director) and Frédéric…Gazette deed
  2. Annual accounts filedfinancial year 2025 · full…
  3. Highest result from 2019 to 2025net €11.5m ▲88.2%

Key points

  • Positive: Turnover rose in 2025from €142.7m to €294.3m ▲ 106% View
  • Positive: Among the best 5% on net resultsector median €113,523 · 6,022 companies €11.5m View
  • Controlled by ELI LILLY NETHERLAND BVknown shareholders 100% 99.99% View
  • New directorslatest change 30-06-2026 · 1 in office 2 joined View
  • Positive: Filed on time since financial year 2020accounts within the deadline every year 6 years View
  • Positive: 6 profitable years in a rowprofit 2025: €11.5m 6 years View
  • Active since 1969founded 19-06-1969 57 years View

By topic

Financials

Financial year
2025
Turnover
€294.3m
Profit
€11.5m
Solvency
25.6%
Turnover▲ 106%
Net result
20192025
Go to Financials

Board & ownership

Board
1 member
Parent
ELI LILLY NETHERLAND BV · 99.99%
Known shareholders
100%
Auditor
EY Réviseurs d'Entreprises SRL
  • Sandrine FerrièreDirector
Go to Board & ownership

Timeline

Events
53
Since
1978
Next accounts
by 31-07-2027
  1. 18-09-2025Reappointment: EY Réviseurs d'Entreprises SRL (statutory auditor)
  2. 29-07-2025Annual accounts filed
  3. 19-07-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
19-06-1969
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.